INSIGHTSInsights that cut through complexity Insights / EducationDrug Treatment of Presbyopia: Medical Necessity or Convenience?Read More Six months after authorization, what do we know about Paxlovid?See this article by RemedyOne EVP of clinical services Robert Louie as it originally appeared in Pharmaphorum. It has now… How the pharmaceutical industry can turn the tide on mental healthMay is Mental Health Awareness Month. RemedyOne president Ralph Pisano wrote this article for Fierce Healthcare about how the pharmaceutical… New Developments in Macular Degeneration/Diabetic Eye DiseaseVisual impairment can be a major health issue for older adults, ranging from a minor inconvenience to vision loss significantly… Drug Innovation Continues Despite a World-Wide PandemicWhile much of the world was on pause during the COVID-19 pandemic, there are definite signs that even a pandemic… Three pharmacy trends that will define 2022See article as it originally appeared in MedCity News. The pharmaceutical industry made more headlines in 2021 than in any… 2022 Q1 RemedyOne Quarterly Pipeline ReportDownload our 2022 Q1 Quarterly Drug Pipeline Report Our quarterly pipeline report provides insight into specialty and traditional drugs in… View All Latest Health Care Education Drug Policy Monthly Drug Spotlight Menu Latest Health Care Education Drug Policy Monthly Drug Spotlight Like what you’re seeing? Get more Insights sent to you. Email NameThis field is for validation purposes and should be left unchanged.